Lipid-Reduction Variability and Antidrug-Antibody Formation with Bococizumab.
N Engl J Med
; 376(16): 1517-1526, 2017 04 20.
Article
in En
| MEDLINE
| ID: mdl-28304227
Full text:
1
Database:
MEDLINE
Main subject:
Antibodies, Monoclonal, Humanized
/
PCSK9 Inhibitors
/
Hypercholesterolemia
/
Cholesterol, LDL
/
Antibodies
/
Anticholesteremic Agents
Type of study:
Clinical_trials
/
Observational_studies
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
N Engl J Med
Year:
2017
Type:
Article